Mutations in the LRRK2 gene, predominantly G2019S, have been reported in individuals with autosomal dominant inheritance and sporadic Parkinson’s disease (PD). The G2019S mutation has an age-dependent penetrance and evidence shows common ancestry. The clinical manifestations are indistinguishable from idiopathic PD. Its prevalence varies according to the population studied ranging from less than 0.1% in Asians to 41% in North African Arabs. This study aimed to identify G2019S mutation in Brazilian idiopathic PD patients. Method: We sampled 100 PD patients and 100 age- and gender-matched controls. Genetical analysis was accomplished by polymerase chain reaction (PCR). Results: No G2019S mutations were found in both patients with sporadic ...
Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been identified in families with aut...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Abstract Background In North African populations, G2019S mutation in LRRK2 gene, encoding for the le...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Background. The LRRK2 G2019S mutation is the most common genetic determinant of Parkinson’s disease ...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Background : The frequency of leucine-rich repeat kinase 2 (LRRK2) G2019S mutation, the most common ...
We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in A...
There is increasing evidence of genetic contribution to the pathogenesis of Parkinson’s disease. The...
7 pagesInternational audienceMutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been id...
Recent discovery of pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene in Parkins...
Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been identified in families with aut...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Abstract Background In North African populations, G2019S mutation in LRRK2 gene, encoding for the le...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Background. The LRRK2 G2019S mutation is the most common genetic determinant of Parkinson’s disease ...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Background : The frequency of leucine-rich repeat kinase 2 (LRRK2) G2019S mutation, the most common ...
We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in A...
There is increasing evidence of genetic contribution to the pathogenesis of Parkinson’s disease. The...
7 pagesInternational audienceMutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been id...
Recent discovery of pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene in Parkins...
Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been identified in families with aut...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Abstract Background In North African populations, G2019S mutation in LRRK2 gene, encoding for the le...